<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30914828</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>06</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5438</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of human genetics : EJHG</Title>
          <ISOAbbreviation>Eur J Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population.</ArticleTitle>
        <Pagination>
          <StartPage>1235</StartPage>
          <EndPage>1243</EndPage>
          <MedlinePgn>1235-1243</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41431-019-0383-8</ELocationID>
        <Abstract>
          <AbstractText>Intellectual disability (ID), megalencephaly, frontal predominant pachygyria, and seizures, previously called "thin" lissencephaly, are reported to be caused by recessive variants in CRADD. Among five families of different ethnicities identified, one homozygous missense variant, c.509G&gt;A p.(Arg170His), was of Finnish ancestry. Here we report on the phenotypic variability associated for this potential CRADD founder variant in 22 Finnish individuals. Exome sequencing was used to identify candidate genes in Finnish patients presenting with ID. Targeted Sanger sequencing and restriction enzyme analysis were applied to screen for the c.509G&gt;A CRADD variant in cohorts from Finland. Detailed phenotyping and genealogical studies were performed. Twenty two patients were identified with the c.509G&gt;A p.(Arg170His) homozygous variant in CRADD. The majority of the ancestors originated from Northeastern Finland indicating a founder effect. The hallmark of the disease is frontotemporal predominant pachygyria with mild cortical thickening. All patients show ID of variable severity. Aggressive behavior was found in nearly half of the patients, EEG abnormalities in five patients and megalencephaly in three patients. This study provides detailed data about the phenotypic spectrum of patients with lissencephaly due to a CRADD variant that affects function. High inter- and intrafamilial phenotypic heterogeneity was identified in patients with pachygyria caused by the homozygous CRADD founder variant. The phenotype variability suggests that additional genetic and/or environmental factors play a role in the clinical presentation. Since frontotemporal pachygyria is the hallmark of the disease, brain imaging studies are essential to support the molecular diagnosis for individuals with ID and a CRADD variant.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Polla</LastName>
            <ForeName>Daniel L</ForeName>
            <Initials>DL</Initials>
            <Identifier Source="ORCID">0000-0002-5552-3488</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rahikkala</LastName>
            <ForeName>Elisa</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Genetics, PEDEGO Research Unit and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bode</LastName>
            <ForeName>Michaela K</ForeName>
            <Initials>MK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Diagnostic Radiology, Oulu University Hospital and Medical Research Center Oulu, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Määttä</LastName>
            <ForeName>Tuomo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Disability Services, Joint Authority for Kainuu, Kainuu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Varilo</LastName>
            <ForeName>Teppo</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Loman</LastName>
            <ForeName>Thyrza</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Philips</LastName>
            <ForeName>Anju K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kurki</LastName>
            <ForeName>Mitja</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Psychiatric &amp; Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palotie</LastName>
            <ForeName>Aarno</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Psychiatric &amp; Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>The Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Körkkö</LastName>
            <ForeName>Jarmo</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Northern Ostrobothnia Hospital District, Center for Intellectual Disability Care, 90220, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vieira</LastName>
            <ForeName>Päivi</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Clinic for Children and Adolescents, PEDEGO Research Unit and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Avela</LastName>
            <ForeName>Kristiina</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jacquemin</LastName>
            <ForeName>Valérie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Genetics, IRIBHM, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pirson</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Genetics, IRIBHM, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abramowicz</LastName>
            <ForeName>Marc</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Genetics, IRIBHM, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>de Brouwer</LastName>
            <ForeName>Arjan P M</ForeName>
            <Initials>APM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuismin</LastName>
            <ForeName>Outi</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Genetics, PEDEGO Research Unit and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Bokhoven</LastName>
            <ForeName>Hans</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Järvelä</LastName>
            <ForeName>Irma</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Genetics, University of Helsinki, Helsinki, Finland. irma.jarvela@helsinki.fi.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>03</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Eur J Hum Genet</MedlineTA>
        <NlmUniqueID>9302235</NlmUniqueID>
        <ISSNLinking>1018-4813</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053420">CRADD Signaling Adaptor Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C104252">CRADD protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C538092">Pachygyria, frontotemporal</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="ErratumIn">
          <RefSource>Eur J Hum Genet. 2019 Sep 10;:</RefSource>
          <PMID Version="1">31506600</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053420" MajorTopicYN="N">CRADD Signaling Adaptor Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005192" MajorTopicYN="N">Family Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018703" MajorTopicYN="Y">Founder Effect</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005843" MajorTopicYN="N">Geography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054082" MajorTopicYN="N">Lissencephaly</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020125" MajorTopicYN="Y">Mutation, Missense</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073359" MajorTopicYN="N">Whole Exome Sequencing</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>2</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30914828</ArticleId>
        <ArticleId IdType="pmc">PMC6777631</ArticleId>
        <ArticleId IdType="doi">10.1038/s41431-019-0383-8</ArticleId>
        <ArticleId IdType="pii">10.1038/s41431-019-0383-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet. 2011;45:81–104. doi: 10.1146/annurev-genet-110410-132512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-genet-110410-132512</ArticleId>
            <ArticleId IdType="pubmed">21910631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willemsen MH, Kleefstra T. Making headway with genetic diagnostics of intellectual disabilities. Clin Genet. 2014;85:101–10. doi: 10.1111/cge.12244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cge.12244</ArticleId>
            <ArticleId IdType="pubmed">23895455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riazuddin S, Hussain M, Razzaq A, Iqbal Z, Shahzad M, Polla DL, et al.  Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability. Mol Psychiatry. 2017;22:1604–14. doi: 10.1038/mp.2016.109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2016.109</ArticleId>
            <ArticleId IdType="pmc">PMC5658665</ArticleId>
            <ArticleId IdType="pubmed">27457812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Institute of Medicine (U.S.). Committee to evaluate the supplemental security income disability program for children with mental disorders. In: Boat TF, Wu JT, editors. National Academies of Sciences Engineering and Medicine: mental disorders and disabilities among low-income children. Washington, D.C.: National Academies Press, 2015. .</Citation>
        </Reference>
        <Reference>
          <Citation>Ropers HH. Genetics of early onset cognitive impairment. Annu Rev Genom Hum Genet. 2010;11:161–87. doi: 10.1146/annurev-genom-082509-141640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-genom-082509-141640</ArticleId>
            <ArticleId IdType="pubmed">20822471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012;135:1348–69. doi: 10.1093/brain/aws019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/brain/aws019</ArticleId>
            <ArticleId IdType="pmc">PMC3338922</ArticleId>
            <ArticleId IdType="pubmed">22427329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 2014;13:710–26. doi: 10.1016/S1474-4422(14)70040-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(14)70040-7</ArticleId>
            <ArticleId IdType="pmc">PMC5548104</ArticleId>
            <ArticleId IdType="pubmed">24932993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerrini R, Marini C. Genetic malformations of cortical development. Exp Brain Res. 2006;173:322–33. doi: 10.1007/s00221-006-0501-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00221-006-0501-z</ArticleId>
            <ArticleId IdType="pubmed">16724181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Donato N, Chiari S, Mirzaa GM, Aldinger K, Parrini E, Olds C, et al.  Lissencephaly: expanded imaging and clinical classification. Am J Med Genet A. 2017;173:1473–88. doi: 10.1002/ajmg.a.38245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.38245</ArticleId>
            <ArticleId IdType="pmc">PMC5526446</ArticleId>
            <ArticleId IdType="pubmed">28440899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, et al.  Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 1993;364:717–21. doi: 10.1038/364717a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/364717a0</ArticleId>
            <ArticleId IdType="pubmed">8355785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parrini E, Conti V, Dobyns WB, Guerrini R. Genetic basis of brain malformations. Mol Syndromol. 2016;7:220–33. doi: 10.1159/000448639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000448639</ArticleId>
            <ArticleId IdType="pmc">PMC5073505</ArticleId>
            <ArticleId IdType="pubmed">27781032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fry AE, Cushion TD, Pilz DT. The genetics of lissencephaly. Am J Med Genet C Semin Med Genet. 2014;166C:198–210. doi: 10.1002/ajmg.c.31402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.c.31402</ArticleId>
            <ArticleId IdType="pubmed">24862549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Donato N, Jean YY, Maga AM, Krewson BD, Shupp AB, Avrutsky MI, et al.  Mutations in CRADD result in reduced caspase-2-mediated neuronal apoptosis and cause megalencephaly with a rare lissencephaly variant. Am J Hum Genet. 2016;99:1117–29. doi: 10.1016/j.ajhg.2016.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2016.09.010</ArticleId>
            <ArticleId IdType="pmc">PMC5097945</ArticleId>
            <ArticleId IdType="pubmed">27773430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harel T, Hacohen N, Shaag A, Gomori M, Singer A, Elpeleg O, et al.  Homozygous null variant in CRADD, encoding an adaptor protein that mediates apoptosis, is associated with lissencephaly. Am J Med Genet A. 2017;173:2539–44. doi: 10.1002/ajmg.a.38347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.38347</ArticleId>
            <ArticleId IdType="pubmed">28686357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, et al.  Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE. 2012;7:e28936. doi: 10.1371/journal.pone.0028936.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0028936</ArticleId>
            <ArticleId IdType="pmc">PMC3260153</ArticleId>
            <ArticleId IdType="pubmed">22279524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kurki MI, Saarentaus E, Pietilainen O, Gormley P, Lal D, Kerminen S et al. Contribution of rare and common variants to intellectual disability in a high-risk population sub-isolate of Northern Finland. bioRxiv. 2019;10:410.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6345990</ArticleId>
            <ArticleId IdType="pubmed">30679432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avela K, Toiviainen-Salo S, Karttunen-Lewandowski P, Kauria L, Valanne L, Salonen-Kajander R. Frontotemporal pachygyria-two new patients. Eur J Med Genet. 2012;55:753–7. doi: 10.1016/j.ejmg.2012.09.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmg.2012.09.007</ArticleId>
            <ArticleId IdType="pubmed">23022981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorva R, Tolppanen EM, Lankinen S, Perheentupa J. [Evaluation of childhood growth] Duodecim. 1985;101:465–76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3987562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karvonen M, Hannila ML, Saari A, Dunkel L. New Finnish reference for head circumference from birth to 7 years. Ann Med. 2012;44:369–74. doi: 10.3109/07853890.2011.558519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/07853890.2011.558519</ArticleId>
            <ArticleId IdType="pubmed">21495784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saari A, Sankilampi U, Hannila ML, Kiviniemi V, Kesseli K, Dunkel L. New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med. 2011;43:235–48. doi: 10.3109/07853890.2010.515603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/07853890.2010.515603</ArticleId>
            <ArticleId IdType="pubmed">20854213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al.  Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91. doi: 10.1038/nature19057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature19057</ArticleId>
            <ArticleId IdType="pmc">PMC5018207</ArticleId>
            <ArticleId IdType="pubmed">27535533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sequencing Initiative Suomi project (SISu), Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland. http://sisuproject.fi. [SISu v4.1, 03/2018].</Citation>
        </Reference>
        <Reference>
          <Citation>Martin AR, Karczewski KJ, Kerminen S, Kurki MI, Sarin AP, Artomov M, et al.  Haplotype sharing provides insights into fine-scale population history and disease in Finland. Am J Hum Genet. 2018;102:760–75. doi: 10.1016/j.ajhg.2018.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajhg.2018.03.003</ArticleId>
            <ArticleId IdType="pmc">PMC5986696</ArticleId>
            <ArticleId IdType="pubmed">29706349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varilo T, Nikali K, Suomalainen A, Lonnqvist T, Peltonen L. Tracing an ancestral mutation: genealogical and haplotype analysis of the infantile onset spinocerebellar ataxia locus. Genome Res. 1996;6:870–5. doi: 10.1101/gr.6.9.870.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gr.6.9.870</ArticleId>
            <ArticleId IdType="pubmed">8889554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan H, Dixit VM. RAIDD is a new ‘death’ adaptor molecule. Nature. 1997;385:86–89. doi: 10.1038/385086a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/385086a0</ArticleId>
            <ArticleId IdType="pubmed">8985253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin Y, Ma W, Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet. 2000;26:122–7. doi: 10.1038/79102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/79102</ArticleId>
            <ArticleId IdType="pubmed">10973264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, Hakem R, et al.  Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc Natl Acad Sci USA. 2005;102:14314–20. doi: 10.1073/pnas.0506475102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0506475102</ArticleId>
            <ArticleId IdType="pmc">PMC1242316</ArticleId>
            <ArticleId IdType="pubmed">16183742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribe EM, Jean YY, Goldstein RL, Manzl C, Stefanis L, Villunger A, et al.  Neuronal caspase 2 activity and function requires RAIDD, but not PIDD. Biochem J. 2012;444:591–9. doi: 10.1042/BJ20111588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20111588</ArticleId>
            <ArticleId IdType="pmc">PMC3365438</ArticleId>
            <ArticleId IdType="pubmed">22515271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shalini S, Dorstyn L, Wilson C, Puccini J, Ho L, Kumar S. Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ. 2012;19:1370–80. doi: 10.1038/cdd.2012.13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2012.13</ArticleId>
            <ArticleId IdType="pmc">PMC3392626</ArticleId>
            <ArticleId IdType="pubmed">22343713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Padalecki SS, Chaudhuri AR, De Waal E, Goins BA, Grubbs B, et al.  Caspase-2 deficiency enhances aging-related traits in mice. Mech Ageing Dev. 2007;128:213–21. doi: 10.1016/j.mad.2006.11.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mad.2006.11.030</ArticleId>
            <ArticleId IdType="pmc">PMC1828128</ArticleId>
            <ArticleId IdType="pubmed">17188333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranta S, Zhang Y, Ross B, Lonka L, Takkunen E, Messer A, et al.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet. 1999;23:233–6. doi: 10.1038/13868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/13868</ArticleId>
            <ArticleId IdType="pubmed">10508524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aula P, Autio S, Raivio KO, Rapola J, Thoden CJ, Koskela SL, et al.  “Salla disease”: a new lysosomal storage disorder. Arch Neurol. 1979;36:88–94. doi: 10.1001/archneur.1979.00500380058006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.1979.00500380058006</ArticleId>
            <ArticleId IdType="pubmed">420628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Renlund M, Aula P, Raivio KO, Autio S, Sainio K, Rapola J, et al.  Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology. 1983;33:57–66. doi: 10.1212/WNL.33.1.57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.33.1.57</ArticleId>
            <ArticleId IdType="pubmed">6681560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kure S, Takayanagi M, Narisawa K, Tada K, Leisti J. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. J Clin Invest. 1992;90:160–4. doi: 10.1172/JCI115831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI115831</ArticleId>
            <ArticleId IdType="pmc">PMC443076</ArticleId>
            <ArticleId IdType="pubmed">1634607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peltonen L, Palotie A, Lange K. Use of population isolates for mapping complex traits. Nat Rev Genet. 2000;1:182–90. doi: 10.1038/35042049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/35042049</ArticleId>
            <ArticleId IdType="pubmed">11252747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Norio R. Finnish disease heritage I: characteristics, causes, background. Hum Genet. 2003;112:441–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12627295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polvi A, Linturi H, Varilo T, Anttonen AK, Byrne M, Fokkema IF, et al.  The Finnish disease heritage database (FinDis) update-a database for the genes mutated in the Finnish disease heritage brought to the next-generation sequencing era. Hum Mutat. 2013;34:1458–66. doi: 10.1002/humu.22389.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.22389</ArticleId>
            <ArticleId IdType="pubmed">23904198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero Delfina M., Bahi-Buisson Nadia, Francis Fiona. Genetics and mechanisms leading to human cortical malformations. Seminars in Cell &amp; Developmental Biology. 2018;76:33–75. doi: 10.1016/j.semcdb.2017.09.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2017.09.031</ArticleId>
            <ArticleId IdType="pubmed">28951247</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
